Cardiovascular Research Advance Access first published online on March 3, 2008
This version [Accepted Manuscript] published online on March 5, 2008
Cardiovascular Research, doi:10.1093/cvr/cvn059
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Contractile smooth muscle cells derived from hair follicle stem cells
1 Bioengineering Laboratory, Department of Chemical and Biological Engineering, University at Buffalo, The State University of New York, Buffalo, NY 14260
2 Center of Excellence in Bioinformatics and Life Sciences, Buffalo, NY 14203
* Address for all Correspondence: Stelios T. Andreadis Bioengineering Laboratory, 908 Furnas Hall, Department of Chemical and Biological Engineering University at Buffalo, State University of New York Amherst, NY 14260 tel: (716) 645-2911 ext. 2204 fax: (716) 645-3822 email: sandread{at}eng.buffalo.edu
Aims: We hypothesized that hair follicle stem cells can differentiate toward smooth contractile muscle cells, providing an autologous cell source for cardiovascular tissue regeneration.
Methods: Smooth muscle cells were obtained from ovine hair follicles using a tissue specific promoter and fluorescence-activated cell sorting.
Results: Hair follicle smooth muscle progenitor cells (HF-SMPC) expressed several markers of vascular smooth muscle including
-actin, calponin, myosin heavy chain, caldesmon, smoothelin and SM22. HF-SMPC were highly proliferative and showed high clonogenic potential without any signs of chromosomal abnormalities as evidenced by karyotype analysis. HF-SMPC compacted fibrin hydrogels to a similar extent as vascular smooth muscle cells from ovine umbilical veins (V-SMC), indicating development of force-generating machinery. In addition, cylindrical tissue equivalents prepared with HF-SMPC displayed significant contractility in response to vasoactive agonists including KCl and the thromboxane A2 mimetic U46619
[GenBank]
, suggesting that these cells had developed receptor and non-receptor-mediated pathways of contractility. Finally, transforming growth factor (TGF)-β1 promoted differentiation of HF-SMPC toward a mature SMC phenotype as suggested by increased expression of myosin heavy chain and enhanced matrix compaction.
Conclusions: Our results suggest that hair follicles may be an easily accessible, autologous and rich source of functional SMPC for cardiovascular tissue engineering and regenerative medicine.
KEYWORDS Stem cells; hair follicle; smooth muscle cells; contractility; cardiovascular tissue engineering; cell therapy
Time for primary review: 32
This is a new version as the previous version was missing two figures.
Related Article
![]()
CiteULike
Connotea
Del.icio.us What's this?
Cardiovasc Res 2008 79: 1-2.